Inference-Time Toxicity Mitigation in Protein Language Models

Modern Protein Language Models (PLMs) apply transformer-based model architectures from natural language processing to biological sequences, predicting a variety of protein functions and properties. However, protein language has key differences from natural language, such as a rich functional space despite a vocabulary of only 20 amino acids. These differences motivate research into how transformer-based architectures operate differently in the protein domain and how we can better leverage PLMs to solve protein-related tasks. In this work, we begin by directly comparing how the distribution of information stored across layers of attention heads differs between the protein and natural language domain. Furthermore, we adapt a simple early-exit technique-originally used in the natural language domain to improve efficiency at the cost of performance-to achieve both increased accuracy and substantial efficiency gains in protein non-structural property prediction by allowing the model to automatically select protein representations from the intermediate layers of the PLMs for the specific task and protein at hand. We achieve performance gains ranging from 0.4 to 7.01 percentage points while simultaneously improving efficiency by over 10 percent across models and non-structural prediction tasks. Our work opens up an area of research directly comparing how language models change behavior when moved into the protein domain and advances language modeling in biological domains.

Protein language models (PLMs) are passive oracles: they generate sequences in a single forward pass with no mechanism to consult external biophysical feedback or redirect generation when a candidate violates thermodynamic or structural constraints. We introduce AgentPLM, which addresses this by equipping a pre-trained PLM with i) Reasoning-Augmented Decoding (RAD), which interleaves autoregressive generation with tool calls (ESMFold, FoldX, AutoDock Vina), and ii) Contrastive Agent Policy Optimisation (CAPO), a trajectory-level extension of direct preference optimisation that trains the policy end-to-end to learn when oracle feedback is informative rather than merely imitating high-fitness sequences. We evaluate AgentPLM on benchmark tasks spanning de novo enzyme design, antibody optimisation, thermostability, PPI interface design, and zero-shot fitness prediction with standardised oracle APIs and controlled sequence-identity splits. AgentPLM achieves state-of-the-art results with a gain in antibody top-10% hit rate over the strongest passive baseline, providing mechanistic evidence of online error correction without explicit backtracking.

Protein modification requires navigating an immense sequence space, yet wet-lab validation remains low-throughput and costly. Although computational paradigms including protein language models (PLMs), large language models (LLMs), and LLM-based agents have shown promise in protein modification, their relative efficacy across realistic experimental decision-making settings remains unclear. To bridge this gap, we introduce PFArena, a benchmark comprising four controlled task interfaces that cover single-mutant generation and multi-mutant ranking. By providing varying levels of mutation fitness data, PFArena reflects four representative research scenarios characterized by differing degrees of prior experimental context. We assess six PLMs, six LLMs, and five LLM-based agents using complementary metrics to measure both peak and overall protein modification performance. Our evaluation reveals that model performance shifts systematically with the availability of target-specific experimental evidence: PLMs demonstrate proficiency in open-ended single-mutant generation by leveraging protein-specific priors, whereas LLMs and agents perform strongly in multi-mutant ranking, particularly when target-specific fitness data are available. Nevertheless, all model families face fundamental challenges with increasing search-space size and mutation depth. We release our code and benchmark suite to facilitate reproducible research in model-assisted protein modification.